A United Kingdom nationally representative survey of public attitudes towards pharmacogenomics.

ABSTRACT:

Background

Variation in DNA is known to contribute to medication response, impacting both medicine effectiveness and incidence of adverse drug reactions (ADRs). However, clinical implementation of pharmacogenomics (PGx) has been slow, and the views of the public are not well understood.

Aim

To assess UK national public attitudes around pharmacogenetics.

Design and methods

The survey was co-designed with the Participant Panel at Genomics England and the data were collected by the National Centre for Social Research, using its nationally representative panel of UK adults. Multivariable logistic regression analyses were used to analyse relationships between selected survey reported variables, controlled for age and sex.

Results

The survey response rate was 58%. Tw

SUBMITTER: Magavern EF 

PROVIDER: S-EPMC12419794 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature